News and Trends 17 Nov 2016
UniQure takes an axe to its Pipeline and Workforce in new R&D Strategy
UniQure just announced a new R&D plan designed to save up to €27M over the next two years. Will the new strategy be enough to pull it out of its down spiral? UniQure is a Dutch biotech famous for launching Glybera, the first commercial gene therapy worldwide. However, the huge price of the treatment has […]